Psoriatic arthritis trials in United Kingdom

In United Kingdom 11 Also abroad 116

11 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Where
Bristol, Liverpool, London, Oxford, Sheffield
Age
1 year to 18 years
People
190 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT03773965
Phase 3Taking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Sheffield, Stoke-on-Trent
Age
3 years to 64 years
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
No phaseTaking people
Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor
Where
Bath
Age
18 years and over
People
700
Run by
Adelphi Real World
See details and how to joinNCT07166315
Phase 3Taking people
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Where
Bristol, Manchester, Nottingham, Stoke-on-Trent
Age
2 years to 18 years
People
40 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT06668181 · EU 2023-508845-41-00
Phase 3Taking people
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Where
Birmingham, Liverpool, Nottingham, Oxford
Age
5 years to 17 years
People
60 worldwide
Run by
Amgen
See details and how to joinNCT04804553 · EU 2023-503435-17-00
Phase 3Taking people
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Where
Bristol, Liverpool, Sheffield
Age
5 years to 17 years
People
40 worldwide
Run by
AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00
No phaseNot yet taking people in United Kingdom
A Study of Clinical and Immune Responses to Sequential Biologic Therapies in Psoriatic Arthritis
Where
Bath
Age
18 years and over
People
400
Run by
Royal United Hospitals Bath NHS Foundation Trust
See details and how to joinNCT07417995
No phaseTaking people
Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
Where
Birmingham, Coventry, Glasgow, Newcastle upon Tyne
Age
18 years to 75 years
People
45
Run by
NHS Greater Glasgow and Clyde
See details and how to joinNCT07443956
No phaseNot yet taking people in United Kingdom
Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis
Where
Glasgow
Age
18 years to 75 years
People
40
Run by
NHS Greater Glasgow and Clyde
See details and how to joinNCT07403890
No phaseTaking people
Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
Where
Glasgow
Age
18 years to 74 years
People
50
Run by
NHS Greater Glasgow and Clyde
See details and how to joinNCT06786936
No phaseTaking people
HIPPOCRATES Prospective Observational Study
Where
Oxford
Age
18 years and over
People
25,000
Run by
University of Oxford
See details and how to joinNCT05858528